Search PDMR transactions

Notifier
Name of person with notification obligation
Axel Schörling
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Axel Schörling
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
EQL Pharma AB
Issuer´s LEI code
549300Q8B2D2AE8GCW21
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subcription warrant Teckningsoption serie2025/2029 Subscription 100,000 Quantity 7.38 SEK 23/08/2025 Outside a trading venue
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Teckningsoption serie2025/2029 Subscription 23/08/2025 Outside a trading venue 100,000 (Quantity) 7.38 SEK
Total: 100,000
<< Back